Showing results (671-680 of 10,067) with videos related to
Sort By:
Pageof 1,007
Current Pharmaceutical Design|September 17, 2009
Rho kinase: an important mediator of atherosclerosis and vascular diseaseQian Zhou, James K LiaoCurrent Pharmaceutical Design|September 17, 2009
Inhibitors of the 5-lipoxygenase pathway in atherosclerosisMagnus BäckCurrent Pharmaceutical Design|September 17, 2009
Oral antidiabetic agents: anti-atherosclerotic properties beyond glucose lowering?N Papanas, E MaltezosCurrent Pharmaceutical Design|April 8, 2010
Current nervous system related drug targets for the treatment of amyotrophic lateral sclerosisAaron C Pawlyk, Joel A Cassel, Allen B ReitzCurrent Pharmaceutical Design|April 8, 2010
Role of adipocytokines in hepatic fibrosisC Bertolani, F MarraCurrent Pharmaceutical Design|April 8, 2010
Leptin: the prototypic adipocytokine and its role in NAFLDClaudio Procaccini, Mario Galgani, Veronica De Rosa, et al.Current Pharmaceutical Design|April 8, 2010
Insulin resistance in nonalcoholic fatty liver diseaseE Bugianesi, S Moscatiello, M F Ciaravella, et al.Current Pharmaceutical Design|April 10, 2009
Aspirin resistance in cardiovascular disease: pathogenesis, diagnosis and clinical impactAthanasios Papathanasiou, John Goudevenos, Alexandros D TselepisCurrent Pharmaceutical Design|April 10, 2009
Design of iodine-lithium-alpha-dextrin liquid crystal with potent antimicrobial and anti-inflammatory propertiesTigran K Davtyan, Levon M Mkhitaryan, Emil S GabrielyanCurrent Pharmaceutical Design|April 10, 2009
Novel inhibitors of HIV discovered among existing classes of pharmaceutical compounds indicated for unrelated clinical indicationsI I Kucherov, P G Rytik, I A Podol'skaya, et al.Pageof 1,007